Defective Breast Mesh, Acellular Dermal Matrix (ADM), and Bioabsorbable Scaffold Injury Attorneys in Richardson: The Complete Guide for Women, Families, and Survivors
If you are reading this in Richardson, it is likely because you or a woman you love is facing a medical crisis that feels as confusing as it is painful. Perhaps you underwent a mastectomy and reconstruction at a major medical center near the Telecom Corridor, or perhaps you chose an aesthetic procedure at a high-volume plastic surgery practice in the North Dallas area. Regardless of the origin of your surgery, if you are now experiencing persistent redness, fluid collection, or a late-onset diagnosis of a rare lymphoma, you are navigating a landscape where the medical technology meant to support you may have actually caused you harm.
We understand the specific anxiety that accompanies a failing reconstruction or a new oncological diagnosis. At The Manginello Law Firm, PLLC, operating under the consumer brand Attorney911, we have dedicated ourselves to representing the victims of institutional neglect and defective medical products. Our Managing Partner, Ralph Manginello, has been licensed by the State Bar of Texas (Bar Card Number 24007597) for over twenty-seven years, and we are admitted to the United States District Court for the Southern District of Texas, as well as handling high-stakes litigation across the state. We bring a level of technical rigor to these cases that generalist personal injury firms cannot match.
The Richardson community is served by some of the most prestigious medical institutions in North Texas, including Methodist Richardson Medical Center and the nearby UT Southwestern Simmons Comprehensive Cancer Center. While these facilities provide critical care, they often utilize medical devices—specifically acellular dermal matrices (ADM) and bioabsorbable scaffolds like GalaFLEX—that were never cleared by the FDA for use in breast surgery. If your health has been compromised by these devices, you need a firm that understands the intersection of 21 CFR federal regulations, Texas product liability law, and complex pathology.
Understanding the Devices: Mesh, ADM, and Bioabsorbable Scaffolds
For many Richardson patients, the terms used in surgical reports are indecipherable. To understand your legal options, we must first look at the three primary categories of devices implicated in this litigation.
1. Acellular Dermal Matrix (ADM)
ADM is a biologic material derived from human cadaver skin or animal tissue (porcine or bovine). In Richardson reconstruction surgeries, ADM is often used to create a pocket for a breast implant, providing “lower pole” support. Brands like AlloDerm (Allergan/AbbVie), Strattice, and FlexHD (MTF Biologics) are common in North Texas operating rooms. However, the FDA’s March 31, 2021, safety communication explicitly warned about differing complication rates for ADM, specifically naming FlexHD and AlloMax as having significantly higher rates of infection and explantation.
2. Bioabsorbable and Resorbable Scaffolds
These are synthetic materials designed to be absorbed by your body over 18 to 24 months. The GalaFLEX Scaffold, manufactured by Tepha/Galatea and now owned by Becton Dickinson (BD), is the leading product in this category. It is composed of poly-4-hydroxybutyrate (P4HB). While marketed as an “internal bra” for mastopexy (breast lift) or reconstruction, the FDA’s November 9, 2023, letter to health care providers stated clearly: “The safety and effectiveness of surgical mesh in breast surgery… has not been determined by the FDA.”
3. Synthetic Mesh
Though less common today in primary breast surgery, permanent synthetic meshes (polypropylene) are sometimes used off-label. These materials were designed for hernia repair, not the delicate tissue of the breast envelope.
If you are currently experiencing complications in Richardson, we invite you to call us at 1-888-ATTY-911 (1-888-288-9911) for a confidential, no-obligation consultation. Our associate attorney, Lupe Peña, is a third-generation Texan who conducts full client consultations in fluent Spanish, ensuring that every Richardson resident has direct access to legal expertise without the barrier of a translator.
The FDA Regulatory Failure and the 510(k) Pathway
One of the most frequent questions we hear from Richardson families is: “How was this allowed to happen if the FDA didn’t approve it?” The answer lies in a regulatory shortcut known as the 510(k) clearance pathway (21 USC §360c).
Under the 510(k) process, a manufacturer does not have to prove a device is safe or effective through clinical trials. Instead, they only have to show it is “substantially equivalent” to a “predicate device” already on the market. This has led to what we call “predicate creep,” where a device like GalaFLEX can trace its ancestry back to a surgical suture—a completely different clinical application.
In Medtronic v. Lohr (518 U.S. 470, 1996), the Supreme Court established that 510(k) clearance is not a finding of safety and effectiveness. This is why we can successfully sue manufacturers like Allergan or Becton Dickinson even if their products were “cleared” by the FDA. They utilized a loophole to place these devices into Richardson bodies without ever conducting the rigorous testing required for a Premarket Approval (PMA) under 21 CFR Part 814.
The Whistleblower: Dr. Hooman Noorchashm and GalaFLEX
The litigation surrounding GalaFLEX in Richardson and across the country was significantly empowered by the testimony of Dr. Hooman Noorchashm. A cardiothoracic surgeon and former Medical Director at Becton Dickinson, Dr. Noorchashm was terminated in 2022 after raising internal alarms about the safety of GalaFLEX in breast surgery.
Dr. Noorchashm’s whistleblower record alleges that BD withheld data regarding breast cancer recurrences in GalaFLEX clinical trials and failed to adequately report hundreds of adverse events to the FDA’s MAUDE database. He has publicly warned surgeons that the malpractice liability for the off-label use of GalaFLEX belongs to them, while the product liability rests with the manufacturer who marketed it to them. At Attorney911, we utilize this whistleblower evidence to demonstrate that the manufacturers were on notice of these dangers long before they alerted patients in Richardson.
The Complication Spectrum: What Richardson Patients Must Know
Complications from these devices can range from aesthetic failure to life-threatening malignancies. If you were treated in a Richardson or Plano surgical center, watch for the following symptoms:
BIA-ALCL (Breast Implant-Associated Anaplastic Large Cell Lymphoma)
This is a rare T-cell lymphoma (not breast cancer) that develops in the scar tissue (capsule) around the implant. It is most strongly associated with textured surfaces, such as the Allergan BIOCELL implants recalled in July 2019. Pathologically, BIA-ALCL is identified as CD30-positive and ALK-negative. If you experience a late-onset seroma (fluid collection) 7 to 10 years after your surgery, this must be investigated immediately.
BIA-SCC (Breast Implant-Associated Squamous Cell Carcinoma)
A distinct epithelial tumor discovered in the implant capsule. The FDA issued an updated safety communication in March 2023 regarding BIA-SCC after reports of three deaths and latency periods ranging from 7 to 42 years post-implantation.
Red Breast Syndrome (RBS)
Unique to acellular dermal matrix (ADM), this is a noninfectious, sterile inflammation where the breast skin turns bright red. Research by Nguyen et al. (2019) suggests this is caused by bacterial endotoxins (LPS) that survive the sterilization process. While the bacteria are dead, their byproduct triggers a massive inflammatory response.
Capsular Contracture
The hardening of the scar tissue around the implant, often scored by the Baker Grade system. When mesh or ADM is involved, the contracture can be particularly aggressive, leading to Baker Grade III or IV, causing severe pain and deformity.
Reconstruction Failure
Skin-flap necrosis and wound dehiscence (opening of the incision) can lead to the “loss of the pocket.” In many Richardson cases, this results in the permanent loss of the reconstruction, forcing patients to undergo flat-closure or complex autologous tissue flaps (like DIEP or TRAM flaps).
Hablamos español. Si usted vive en Richardson y ha sufrido complicaciones por malla de seno o ADM, Lupe Peña puede asistirla en su propio idioma. Llame al 1-888-ATTY-911 para una consulta gratuita.
Why Technical Authority Matters in Richardson Device Litigation
When you are fighting global corporations like AbbVie (Allergan) or Becton Dickinson, you cannot afford a “generalist” attorney who mainly handles car accidents. You need a firm that understands the Riegel/Lohr/Buckman/Daubert/Perez v. Wyeth preemption map.
For instance, manufacturers often argue that Richardson cases are “preempted” by federal law under Riegel v. Medtronic (2008). However, because these devices were cleared via 510(k) rather than PMA, they generally do not enjoy this immunity. Furthermore, we pursue “parallel claims”—arguing that the manufacturer violated state law by failing to comply with federal Medical Device Reporting (MDR) requirements under 21 CFR Part 803.
We have a proven history of tackling multi-defendant, high-stakes institutional liability. For example, Ralph Manginello and Lupe Peña are currently lead counsel in Bermudez v. Pi Kappa Phi Fraternity, Inc., a $10,000,000 lawsuit filed in November 2025 involving thirteen defendants. This case, which garnered significant media attention from KPRC 2, ABC13, and FOX 26, demonstrates our capability to manage the structural complexity required for medical device mass torts.
The Richardson Statute of Limitations and Discovery Rule
In Texas, the statute of limitations for a product liability claim is generally two years from the date the injury occurred or was discovered (Texas Civil Practice & Remedies Code § 16.03). However, for women in Richardson with implanted devices, the “discovery rule” is critical.
If you had your surgery five years ago but only developed a seroma or received a BIA-ALCL diagnosis last month, your two-year clock may only have started ticking recently. Additionally, Texas has a 15-year statute of repose for most product cases. Because these cases are technically and legally complex, waiting even a few months can jeopardize your ability to recover.
Ralph Manginello’s twenty-seven years of practice and our firm’s 4.9 out of 5.0-star rating across hundreds of Birdeye and Avvo reviews reflect our commitment to meeting these deadlines and providing aggressive representation for the Richardson community.
Precedent Verdicts and Settlements: What Is at Stake?
While every case is unique, the history of mesh and medical device litigation shows that the justice system can hold these companies accountable. At Attorney911, we look at precedents to gauge the potential value of Richardson claims:
- Hernia Mesh Precedents: In October 2024, Becton Dickinson (the maker of GalaFLEX and Phasix) agreed to a settlement estimated at over $1 billion to resolve roughly 40,000 hernia mesh claims. This followed bellwether verdicts ranging from $255,000 to $4.8 million.
- Pelvic Mesh Precedents: Over $8 billion has been paid to more than 100,000 women injured by transvaginal mesh, with individual verdicts sometimes reaching eight figures, such as the $57.1 million verdict against Ethicon in 2017.
- Plastic Surgery Malpractice: We have seen settlements as high as $40 million for severe infection and permanent disfigurement following breast procedures.
We fight for Richardson patients to recover “economic damages” (past and future medical bills, lost wages) and “non-economic damages” (pain and suffering, permanent scarring, loss of sensation, and loss of enjoyment of life).
Evidence Preservation for Richardson Plaintiffs
If you suspect your ADM or mesh is failing, do not wait for the manufacturer to act. You must be proactive in preserving evidence:
- Request Your Operative Report: Hospitals in the Richardson area are required to maintain these records. Look for the “Unique Device Identifier” (UDI) or the implant stickers.
- Secure Your Explanted Device: If you undergo revision surgery, the mesh or scaffold is your property. We can assist in ensuring the pathology lab does not destroy the device, as it is a critical piece of physical evidence.
- Pathology Slides: Request the actual slides and blocks from your biopsies. Independent pathologists can re-review these for BIA-ALCL biomarkers (CD30).
- Photography: Document any visible redness, swelling, or asymmetry.
If you need help securing these records from a provider in the Richardson or Collin County area, call 1-888-ATTY-911 today.
Frequently Asked Questions for Richardson Residents
1. Is GalaFLEX approved by the FDA for “internal bra” lift procedures?
No. GalaFLEX is cleared for general soft-tissue reinforcement. Its use in breast lifts or mastopexy is “off-label.” The FDA stated in 2023 that its safety for this purpose has not been determined.
2. I live in Richardson but had my surgery in Dallas. Where do I file?
Suit can often be filed in the county where the injury occurred or where the defendant maintains an office. For federal cases, the Northern District of Texas (Dallas Division) typically hears cases arising in Richardson.
3. What if I can’t afford an attorney?
At Attorney911, we operate on a contingency fee basis. This means you pay nothing up-front, and we only receive a fee if we recover compensation for you. We take on the financial risk of the litigation so you can focus on your health.
4. Can I sue if my mesh hasn’t caused cancer yet?
Yes. Complications like Red Breast Syndrome, chronic pain, mesh extrusion, and reconstruction failure are all actionable “physical injuries” under Texas law, regardless of a cancer diagnosis.
5. How long will a breast mesh lawsuit take in Richardson?
Device litigation is a marathon, not a sprint. Coordinated proceedings like MDL 2921 have timelines that can span several years. However, filing early ensures you are included in the settlement classes that form as a result of bellwether trials.
6. Is Lupe Peña available for a consultation in Richardson?
Yes, Lupe Peña and our team serve the Richardson community. We can conduct consultations via phone, video, or in person at our principal office. Lupe’s bilingual capability is a significant advantage for our Spanish-speaking clients.
7. I have Baker Grade IV capsular contracture. Is that considered a “defective” injury?
If the contracture was caused by the inflammatory response to a textured implant or a specific brand of ADM (like FlexHD), it may be grounds for a product liability claim.
8. What did the November 2023 FDA letter change?
It forced manufacturers to update their labels to admit they had no data on the safety of mesh in breast reconstruction. For many Richardson women, this was the “discovery” moment that allowed them to finally connect their injuries to the device.
9. Can I sue the hospital as well as the manufacturer?
In some cases, yes, under a theory of negligent credentialing or failure to warn, though manufacturer liability is usually the primary avenue.
10. What is the “Bermudez” case I keep seeing?
Bermudez v. Pi Kappa Phi is a major $10 million lawsuit led by Ralph Manginello and Lupe Peña. It is proof of our firm’s ability to take on large, complex, multi-defendant institutional cases—exactly like those against mesh manufacturers.
Why Attorney911 Is the Choice for Richardson Survivors
We are not just a law firm; we are a resource for the Richardson community. Our managing partner, Ralph Manginello, is a member of the Pro Bono College of the State Bar of Texas, a distinction reserved for those who provide over 75 hours of pro bono service annually. This commitment to service permeates everything we do.
Our credentials speak for themselves:
- Ralph Manginello: Avvo “Excellent” 8.2 rating; 5.0-star client review score; Martindale-Hubbell Peer Review Rated; member of the National Association of Italian Lawyers and the New York State Bar Association.
- Lupe Peña: Associate Attorney with a focus on wrongful death and premises liability; admitted to the Southern District of Texas; offers full bilingual services.
- Media Recognition: Our cases have been featured on ABC13, KPRC 2, and in Houston Public Media, identifying us as a firm that the media trusts for legal insight.
Whether you are a breast cancer survivor at a facility in Richardson who has lost your reconstruction, or an aesthetic patient whose “internal bra” has caused a nightmare of chronic pain, we are here for you. We provide a compassionate, hyper-scientific, and doctrinally rigorous approach to medical device injury.
Contact Us Today — Richardson Defenders of Patient Rights
The path to justice starts with a single conversation. Do not let the statute of limitations expire while you “wait and see” how you feel. The evidence in your case—your medical records and the mesh currently in your body—must be protected.
Call 1-888-ATTY-911 (1-888-288-9911) for your free, confidential consultation.
You can also reach us through our primary office:
The Manginello Law Firm, PLLC
1177 West Loop South, Suite 1600
Houston, Texas 77027
Even though our principal office is in Houston, we serve clients in Richardson, Austin, Beaumont, and throughout the state of Texas. We have the federal court admissions and the sophisticated case history required to take on national medical device manufacturers on behalf of Richardson residents.
Hablamos su idioma. No cobramos si no ganamos. We are ready to listen to your story and help you hold the manufacturers of defective breast mesh, ADM, and scaffolds accountable for the harm they have caused. Your health, your dignity, and your future in Richardson are worth the fight.
Take the first step toward recovery. Call 1-888-ATTY-911 today.
